| Literature DB >> 26584347 |
Siddarth Chandrasekaran1, Maxine F Chan1, Jiahe Li1, Michael R King2.
Abstract
Tumor draining lymph nodes are the first site of metastasis in most types of cancer. The extent of metastasis in the lymph nodes is often used in staging cancer progression. We previously showed that nanoscale TRAIL liposomes conjugated to human natural killer cells enhance their endogenous therapeutic potential in killing cancer cells cultured in engineered lymph node microenvironments. In this work, it is shown that liposomes decorated with apoptosis-inducing ligand TRAIL and an antibody against a mouse natural killer cell marker are carried to the tumor draining inguinal lymph nodes and prevent the lymphatic spread of a subcutaneous tumor in mice. It is shown that targeting natural killer cells with TRAIL liposomes enhances their retention time within the tumor draining lymph nodes to induce apoptosis in cancer cells. It is concluded that this approach can be used to kill cancer cells within the tumor draining lymph nodes to prevent the lymphatic spread of cancer.Entities:
Keywords: Liposomes; Nanotechnology; Natural killer cells; TRAIL; Tumor-draining lymph nodes
Mesh:
Substances:
Year: 2015 PMID: 26584347 PMCID: PMC4684422 DOI: 10.1016/j.biomaterials.2015.11.001
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479